Private semaglutide in the UK: the honest guide

Is semaglutide available privately, and what does that involve?

Yes. Semaglutide in the UK is available privately through regulated online pharmacies and private clinics, prescribed under the brand name Wegovy. It is a prescription-only medicine, which means no pharmacy (online or high street) can supply it without a valid prescription from an authorised prescriber. That is not a technicality; it is the law under the Human Medicines Regulations 2012.

In practical terms, private access removes two of the biggest barriers people face with NHS routes: the GP referral step and the waiting list. You do not need your GP's sign-off to start a private consultation. What you do still need is a clinical assessment, someone qualified checking that the medicine is appropriate for you, that there are no contraindications, and that you understand the treatment. At nume, that assessment is carried out by a GPhC-registered Independent Prescriber, a real clinician reading your answers the same day, not an automated filter.

Once approved, the medicine is dispensed from a GPhC-registered pharmacy and delivered to your door. If you order before 12pm on a weekday, it can leave the same day, the kind of turnaround that matters when you have been waiting months on an NHS list. You can read more about the full private route on our private Wegovy in the UK page.

The NHS route, for context, requires meeting NICE criteria under TA875, which specifies use within a specialist weight management service, for a maximum of two years, with a BMI of at least 35 alongside a weight-related condition. Many people either do not meet those criteria or cannot wait. Private prescribing follows the medicine's licensed eligibility rather than NICE's commissioning thresholds, so the bar is lower and the process is faster.

Who meets the eligibility criteria for private semaglutide in the UK?

The licensed eligibility for Wegovy sits in the medicine's Summary of Product Characteristics, and it is reasonably straightforward. Adults with a BMI of 30 or above qualify on BMI alone. Those with a BMI between 27 and 29.9 can also be eligible if they have at least one weight-related condition, hypertension, type 2 diabetes, high cholesterol, obstructive sleep apnoea and osteoarthritis are among the recognised examples. For some ethnic backgrounds, UK guidance applies BMI thresholds that are 2.5 kg/m² lower than the standard figures; our Wegovy overview covers this in more detail.

BMI alone does not guarantee a prescription. The prescriber considers the full picture: your health history, any medicines you already take, conditions that might make semaglutide unsuitable (certain thyroid conditions, a history of pancreatitis, or pregnancy, for example), and whether the benefits outweigh any individual risks. People who are pregnant, breastfeeding or trying to conceive should not take semaglutide; nor should those under 18.

There is no upper age limit in the licence, but older adults with complex health histories may require more detailed assessment. Transfer patients (those switching from another provider) and those requesting a dose increase will typically be asked to provide evidence of their current treatment and weight progress. That step exists to protect you, not to slow things down. The private Wegovy prescription page goes into the clinical assessment process in more depth.

What does the evidence say about semaglutide's effectiveness?

The trial data is robust. In the STEP 1 trial, published in the New England Journal of Medicine, adults without diabetes who took semaglutide 2.4mg weekly for 68 weeks lost an average of around 15% of their body weight, compared with around 2.4% in the placebo group. That is a meaningful difference, and it was achieved alongside a reduced-calorie diet and increased physical activity, not semaglutide alone.

Since those results were published, the available dose range has expanded. The MHRA approved a 7.2mg maintenance dose in January 2026, with a dedicated single-dose 7.2mg pen following in April 2026. Trials at the higher dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with tirzepatide 15mg. Whether that higher dose is suitable for any individual is a clinical decision. You can compare the two medicines in more detail on our weight loss treatments page.

What the trials do not tell you is how you personally will respond. Semaglutide does not work the same way in everyone; genetics, baseline weight, diet adherence and other factors all play a role. No service can promise a specific outcome, and any that does should be viewed with scepticism. The NHS summarises what is currently known about semaglutide's effects and side effects on its medicines page for semaglutide.

What about cost, side effects and ongoing safety?

The most common side effects of semaglutide are gastrointestinal: nausea, constipation, diarrhoea, indigestion and occasionally vomiting. These tend to be most noticeable in the early weeks of treatment or after a dose step-up, and many people find they settle as the body adjusts. Staying well hydrated and eating smaller, lower-fat meals can help. Pancreatitis is a less common but more serious possibility; the symptom to know is severe abdominal pain that radiates towards the back. If that happens, stop the medicine and get urgent medical help.

On cost: private semaglutide in the UK is priced per monthly supply, and prices vary between providers. Following Eli Lilly's list price changes in September 2025, the broader private market shifted, and typical monthly costs across providers now range roughly from £149 to £375 depending on dose. For pricing specific to Wegovy's cost, that page sets out what the figures include, and what cheap-looking prices from unverified sellers often leave out. A legitimate price covers the prescription and clinical assessment. Some listings do not.

Selling these medicines without a prescription is illegal, and the MHRA has seized large quantities of fake weight-loss pens over the past two years. If you are trying to find out what pharmacies have Wegovy in stock right now, our dedicated page tracks availability so you are not left guessing. Verifying the pharmacy you use on the GPhC register takes about 30 seconds and is worth doing for any online provider. For people who are ready to buy semaglutide privately and want a clinical assessment with no GP referral required, speaking to our prescribers is a sensible starting point.